| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
American Journal of Transplantation: Volume 21, Number 4, April 2021
|
|
|
|
21 |
4 |
p. i
|
article
|
| 2 |
A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation
|
Nickerson, Peter W.
|
|
|
21 |
4 |
p. 1503-1512
|
article
|
| 3 |
B cells and extracellular vesicles: New key players in solid organ transplantation?
|
Colas, Luc
|
|
|
21 |
4 |
p. 1361-1362
|
article
|
| 4 |
Biliary obstruction following ureteral revision of a transplanted kidney
|
Thiessen, Carrie
|
|
|
21 |
4 |
p. 1657-1659
|
article
|
| 5 |
B lymphocytes contribute to indirect pathway T cell sensitization via acquisition of extracellular vesicles
|
Becker, Pablo D.
|
|
|
21 |
4 |
p. 1415-1426
|
article
|
| 6 |
Combining cell-based therapy and normothermic machine perfusion for kidney graft conditioning has gone one step further
|
Steichen, Clara
|
|
|
21 |
4 |
p. 1359-1360
|
article
|
| 7 |
COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients
|
Craig-Schapiro, Rebecca
|
|
|
21 |
4 |
p. 1576-1585
|
article
|
| 8 |
COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination — United States, September and December 2020
|
Nguyen, Kimberly H.
|
|
|
21 |
4 |
p. 1650-1656
|
article
|
| 9 |
Defining the roles and responsibilities of the kidney transplant medical director: A necessary step for future training, mentoring, and professional development
|
C. Wiseman, Alexander
|
|
|
21 |
4 |
p. 1556-1563
|
article
|
| 10 |
Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation
|
Motter, Jennifer D.
|
|
|
21 |
4 |
p. 1612-1621
|
article
|
| 11 |
De novo HLA-alloimmunization to a kidney allograft incidentally without anastomoses
|
Friedersdorff, Frank
|
|
|
21 |
4 |
p. 1665-1666
|
article
|
| 12 |
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?
|
Massat, Maéva
|
|
|
21 |
4 |
p. 1641-1649
|
article
|
| 13 |
Erratum
|
|
|
|
21 |
4 |
p. 1675
|
article
|
| 14 |
Erratum
|
|
|
|
21 |
4 |
p. 1676-1677
|
article
|
| 15 |
Expanding living donor liver transplantation: Report of first US living donor liver transplant chain
|
Braun, Hillary J.
|
|
|
21 |
4 |
p. 1633-1636
|
article
|
| 16 |
Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity
|
Einecke, Gunilla
|
|
|
21 |
4 |
p. 1391-1401
|
article
|
| 17 |
Fatal metabolic stroke in a child with propionic acidemia 11 years post liver transplant
|
Sivananthan, Siyamini
|
|
|
21 |
4 |
p. 1637-1640
|
article
|
| 18 |
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
|
Harden, Paul N.
|
|
|
21 |
4 |
p. 1603-1611
|
article
|
| 19 |
Fecal microbiota transplant boosts cancer immunotherapy in patients
|
Li, Xian C.
|
|
|
21 |
4 |
p. 1355
|
article
|
| 20 |
Harnessing T cell exhaustion to improve solid organ transplant outcomes
|
Levitsky, Josh
|
|
|
21 |
4 |
p. 1660-1661
|
article
|
| 21 |
Impact of ischemia time on islet isolation success and posttransplantation outcomes: A retrospective study of 452 pancreas isolations
|
Wassmer, Charles-Henri
|
|
|
21 |
4 |
p. 1493-1502
|
article
|
| 22 |
Islet or pancreas after kidney transplantation: Is the whole still greater than some of its parts?
|
Fridell, Jonathan A.
|
|
|
21 |
4 |
p. 1363-1364
|
article
|
| 23 |
Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?
|
Mendoza, Maria A.
|
|
|
21 |
4 |
p. 1670-1671
|
article
|
| 24 |
Liver transplantation in a patient after COVID-19 – Rapid loss of antibodies and prolonged viral RNA shedding
|
Niess, Hanno
|
|
|
21 |
4 |
p. 1629-1632
|
article
|
| 25 |
Management of lung transplantation in the COVID-19 era—An international survey
|
Coiffard, Benjamin
|
|
|
21 |
4 |
p. 1586-1596
|
article
|
| 26 |
Microvascular obstructions in portal bile duct capillaries and hepatic sinusoids during normothermic machine perfusion of marginal human livers
|
Tingle, Samuel J.
|
|
|
21 |
4 |
p. 1662-1664
|
article
|
| 27 |
Normothermic kidney perfusion: An overview of protocols and strategies
|
Elliott, Tegwen R.
|
|
|
21 |
4 |
p. 1382-1390
|
article
|
| 28 |
Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation
|
Thompson, Emily R.
|
|
|
21 |
4 |
p. 1402-1414
|
article
|
| 29 |
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes
|
Markmann, James F.
|
|
|
21 |
4 |
p. 1477-1492
|
article
|
| 30 |
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection
|
Cassaniti, Irene
|
|
|
21 |
4 |
p. 1622-1628
|
article
|
| 31 |
Prediction is hard, especially regarding the future a
|
Smith, R. Neal
|
|
|
21 |
4 |
p. 1357-1358
|
article
|
| 32 |
Protective effect of a novel clinical-grade small molecule necrosis inhibitor against oxidative stress and inflammation during islet transplantation
|
Kim, Gyuri
|
|
|
21 |
4 |
p. 1440-1452
|
article
|
| 33 |
Quantifying infection risks in incompatible living donor kidney transplant recipients
|
Avery, Robin K.
|
|
|
21 |
4 |
p. 1564-1575
|
article
|
| 34 |
Response to “Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?”
|
Molnar, Miklos Z.
|
|
|
21 |
4 |
p. 1672-1673
|
article
|
| 35 |
Response to “Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?”
|
Alangaden, George J.
|
|
|
21 |
4 |
p. 1674
|
article
|
| 36 |
SARS-CoV-2 viral dynamics in immunocompromised patients
|
Caillard, Sophie
|
|
|
21 |
4 |
p. 1667-1669
|
article
|
| 37 |
Simultaneous bilateral laparoscopic nephrectomy with kidney transplantation in patients with ESRD due to ADPKD: A single-center experience
|
Abrol, Nitin
|
|
|
21 |
4 |
p. 1513-1524
|
article
|
| 38 |
Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure
|
Spaggiari, Mario
|
|
|
21 |
4 |
p. 1525-1534
|
article
|
| 39 |
Spanish experience with heart transplants from controlled donation after the circulatory determination of death using thoraco-abdominal normothermic regional perfusion and cold storage
|
Miñambres, Eduardo
|
|
|
21 |
4 |
p. 1597-1602
|
article
|
| 40 |
T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy
|
Habal, Marlena V.
|
|
|
21 |
4 |
p. 1465-1476
|
article
|
| 41 |
TGR5/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury
|
Zhou, Haoming
|
|
|
21 |
4 |
p. 1453-1464
|
article
|
| 42 |
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update
|
Witkowski, Piotr
|
|
|
21 |
4 |
p. 1365-1375
|
article
|
| 43 |
The Economy of Transplant: Saving Money and Saving Lives
|
Pullen, Lara C.
|
|
|
21 |
4 |
p. 1353-1354
|
article
|
| 44 |
The use of third-party packed red blood cells during ex situ normothermic machine perfusion of organs for transplantation: Underappreciated complexities?
|
Callaghan, Chris J.
|
|
|
21 |
4 |
p. 1376-1381
|
article
|
| 45 |
TLR-MyD88 signaling blockades inhibit refractory B-1b cell immune responses to transplant-related glycan antigens
|
Sakai, Hiroshi
|
|
|
21 |
4 |
p. 1427-1439
|
article
|
| 46 |
Urinary liver-type fatty acid-binding protein is independently associated with graft failure in outpatient kidney transplant recipients
|
Yepes-Calderón, Manuela
|
|
|
21 |
4 |
p. 1535-1544
|
article
|
| 47 |
Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients
|
Blydt-Hansen, Tom D.
|
|
|
21 |
4 |
p. 1545-1555
|
article
|
Journal description